Recurrent Herpes Zoster Ophthalmicus Preceded by Anabolic Steroids and High-Dose L-Arginine.


Journal

Case reports in ophthalmological medicine
ISSN: 2090-6722
Titre abrégé: Case Rep Ophthalmol Med
Pays: United States
ID NLM: 101581018

Informations de publication

Date de publication:
2020
Historique:
received: 29 08 2020
accepted: 30 09 2020
entrez: 18 1 2021
pubmed: 19 1 2021
medline: 19 1 2021
Statut: epublish

Résumé

To report a case of a 34-year-old male with recurrent herpes zoster ophthalmicus (HZO) preceded by a 6-week cycle of anabolic steroids and high-dose amino acid supplementation. In vitro L-arginine supplementation has been associated with the proliferation and virulence of a variety of herpes viruses. Anabolic steroids have also been demonstrated by various studies to negatively affect cell-mediated immunity necessary to prevent viral infection. Thus, it is possible that anabolic steroids in conjunction with increased L-arginine intake may have precipitated a recurrent HZO in a previously healthy, immunocompetent individual.

Identifiants

pubmed: 33457029
doi: 10.1155/2020/8861892
pmc: PMC7785356
doi:

Types de publication

Case Reports

Langues

eng

Pagination

8861892

Informations de copyright

Copyright © 2020 Stephen A. LoBue et al.

Déclaration de conflit d'intérêts

The following authors have no financial disclosures or conflicts of interest: SAL, AG, RAG, SMC, MB, SA, TDL. The abstract was presented as a digital poster at the 2020 American Society of Cataract and Refractive Surgeons.

Références

Virus Res. 2001 Mar;73(2):177-82
pubmed: 11172921
Am J Ophthalmol Case Rep. 2019 Aug 20;16:100547
pubmed: 31497676
J Gen Intern Med. 2005 Aug;20(8):748-53
pubmed: 16050886
Ophthalmology. 2008 Feb;115(2 Suppl):S3-12
pubmed: 18243930
Regul Toxicol Pharmacol. 2008 Apr;50(3):376-99
pubmed: 18325648
Mayo Clin Proc. 2011 Feb;86(2):88-93
pubmed: 21220354
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979 Jan 15;209(3):219-24
pubmed: 311176
MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4
pubmed: 18528318
Cornea. 2015 May;34(5):535-40
pubmed: 25710509
J Gen Virol. 1978 May;39(2):281-92
pubmed: 650177
J Steroid Biochem Mol Biol. 1990 Sep;37(1):71-6
pubmed: 2242353
J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S13-7
pubmed: 19553630
Mayo Clin Proc. 2013 Jun;88(6):562-70
pubmed: 23664666
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74
pubmed: 24367114
Int J Immunopharmacol. 1995 Nov;17(11):857-63
pubmed: 8788115
Acta Microbiol Acad Sci Hung. 1975;22(3):263-70
pubmed: 168739
Drug Chem Toxicol. 2000 Nov;23(4):621-44
pubmed: 11071398
J Bacteriol. 1964 Mar;87:609-13
pubmed: 14127578
Antiviral Res. 2016 Aug;132:13-25
pubmed: 27192555
Int J Mol Med. 2009 Apr;23(4):495-9
pubmed: 19288025
Adv Virol. 2011;2011:572868
pubmed: 22312346

Auteurs

Stephen A LoBue (SA)

Department of Ophthalmology, SUNY Downstate, Brooklyn, NY 11203, USA.
LoBue Laser & Eye Medical Centers, Murrieta, CA 92562, USA.

Adam Goldman (A)

Department of Ophthalmology, SUNY Downstate, Brooklyn, NY 11203, USA.

Richard A Giovane (RA)

LV Stabler Hospital, Greenville, AL 36037, USA.

Stacy M Carlson (SM)

Montefiore Medical Center, Bronx, NY 10467, USA.

Michael Bivona (M)

Department of Ophthalmology, SUNY Downstate, Brooklyn, NY 11203, USA.

Sinan Albear (S)

Department of Ophthalmology, SUNY Downstate, Brooklyn, NY 11203, USA.

Thomas D LoBue (TD)

LoBue Laser & Eye Medical Centers, Murrieta, CA 92562, USA.

Classifications MeSH